Functional impairment in aged rats chronically exposed to human range dietary aluminum equivalents

NeuroToxicology

Volumn 30, Issue 2, 2009, Pages 182-193

  Walton, J R ^a  

^a Institute for Biomedical Research   (Australia)

Author keywords

Aging; Aluminum chloride; Alzheimer's disease; Animal model; Cognitive damage; Dementia; Hippocampus

Indexed keywords

ALUMINUM SALT; ALUMINUM;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIETARY INTAKE; ENTORHINAL CORTEX; FUNCTIONAL DISEASE; LONGEVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SCORING SYSTEM; SPATIAL MEMORY; AGING; ANIMAL; BLOOD; CHEMICALLY INDUCED; COGNITIVE DEFECT; COMPARATIVE STUDY; DRUG EFFECTS; HUMAN; LONGITUDINAL STUDY; MAZE TEST; MEMORY; PHYSIOLOGY; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE; TOXICITY; WISTAR RAT;

AGING; ALUMINUM; ANIMALS; COGNITION DISORDERS; HUMANS; LONGITUDINAL STUDIES; MALE; MAZE LEARNING; MEMORY; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 61849138379     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2008.11.012     Document Type: Article

References (78)

1. Alexandrov P.N., Zhao Y., Pogue A.I., Tarr M.A., Kruck T.P., Percy M.E., et al. Synergistic effects of iron and aluminum on stress-related gene expression in primary human neural cells. J Alzheimer's Dis 8 (2005) 117-127
2. Armstrong R.A., Anderson J., Cowburn J.D., Cox J., and Blair J.A. Aluminium administered in drinking water but not in the diet influences biopterin metabolism in the rodent. Biol Chem Hoppe-Seyler 373 (1992) 1075-1078
3. Bannerman D.M., Yee B.K., Good M.A., Heupel M.J., Iversen S.D., and Rawlins J.M. Double dissociation of function within the hippocampus: a comparison of dorsal, ventral, and complete hippocampal cytotoxic lesions. Behav Neurosci 113 (1999) 1170-1188
4. Burek J.D. Pathology of the aging rat (1978), CRC Press, West Palm Beach
5. Caporaso G.L., Gandy S.E., Buxbaum J.D., Ramabhadran T.V., and Greengard P. Protein phosphorylation regulates secretion of Alzheimer β/A4 amyloid precursor protein. Proc Natl Acad Sci USA 89 (1992) 3055-3059
6. Cochran M., Elliott D.C., Brennan P., and Chawtur V. Inhibition of protein kinase C activation by low concentrations of aluminium. Clin Chim Acta 194 (1990) 167-172
7. Committee on Food Additives Survey Data. Poundage update of food chemicals 1982, PB 84-16214 (1984), Natl Acad Press, Washington, DC
8. Committee on the GRAS List Survey. Phase III. Estimates of daily intake. In: The 1977 survey of industry on the use of food additives, vol. 3. Washington, D.C.: Natl Acad Sci; 1979.
9. Corrigan F.M., Crichton J.S., Van Rhijn A.G., Skinner E.R., and Ward N.I. Transferrin, cholesterol and aluminium in Alzheimer's disease. Clin Chim Acta 211 (1992) 121-123
10. Dahlgren K.N., Manelli A.M., Stine Jr. W.B., Baker L.K., Krafft G.A., and LaDu M.J. Oliogomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J Biol Chem 277 (2002) 32046-32053
11. David J., and Grewal R.S. A simplified technique for producing aluminum hydroxide-induced chronic focal seizures in monkeys. Ind J Exp Biol 16 (1977) 96-99
12. Drüeke T.B. Intestinal absorption of aluminium in renal failure. Nephrol Dial Transplant 17 Suppl 2 (2002) 13-16
13. Drüeke T.B., Jouhanneau P., Banide H., Lacour B., Yiou F., and Raisbeck G. Effects of silicon, citrate and the fasting state on the intestinal absorption of aluminium in rats. Clin Sci 92 (1997) 63-67
14. Edwardson J.A., Moore P.B., Ferrier I.N., Lilley J.S., Newton G.W.A., Barker J., et al. Effect of silicon on gastrointestinal absorption of aluminium. Lancet 342 (1993) 211-212
15. Everitt A.V. Ageing rat colonies at the University of Sydney. Proc Aust Assoc Gerontol 26 (1991) 79-82
16. Exley C., Price N.C., Kelly S.M., and Birchall J.D. An interaction of beta-amyloid with aluminium in vitro. FEBS Lett 324 (1993) 293-295
17. Flaten T.P. Aluminium as a risk factor in Alzheimer's disease, with emphasis on drinking water. Brain Res Bull 55 (2001) 187-196
18. Flood D.G., Buell S.J., Defiore C.H., Horwitz G.J., and Coleman P.D. Age-related dendritic growth in dentate gyrus of human brain is followed by regression in the 'oldest old'. Brain Res 345 (1985) 366-368
19. Gauthier E., Fortier I., Courchesne F., Pepin P., Mortimer J., and Gauvreau D. Aluminum forms in drinking water and risk of Alzheimer's disease. Environ Res 84 (2000) 234-246
20. Golub M., and Keen C. Neurotoxicity testing guidelines should be used to conduct a study that will serve as the basis for an aluminum drinking water standard. Report of the Workshop on the feasibility of a chronic neurotoxicity study of aluminum administered in the drinking water of animals (1997), Health Canada & USEPA, Toronto pp. 25-30
21. Gong C.-X., Lidsky T., Wegiel J., Zuck L., and Grundke-Iqbal I. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J Biol Chem 275 (2000) 5535-5544
22. Greger J.L. Aluminum content of the American diet. Food Technol 9 (1985) 73-80
23. Greger J.L. Aluminum metabolism. Annu Rev Nutr 13 (1993) 43-63
24. Greger J.L., and Baier M.J. Excretion and retention of low or moderate levels of aluminium by human subjects. Food Chem Toxicol 21 (1983) 473-477
25. Gutteridge J.M.C., Quinlan G.J., Clark I., and Halliwell B. Aluminum salts accelerate peroxidation of membrane lipids stimulated by iron salts. Biochem Biophys Acta 835 (1985) 441-447
26. Hommet C., Hureaux R., Barre J., Constans T., and Berrut G. Epileptic seizures in clinically diagnosed Alzheimer's disease: report from a geriatric medicine population. Aging-Clin Exp Res 19 (2007) 430-431
27. House E., Collingwood J., Khan A., Korchazkina O., Berthon G., and Exley C. Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease. J Alzheimer's Dis 6 (2004) 291-301
28. Humphreys S., and Bolger P.M. A public health analysis of dietary aluminium. In: Zatta P.F., and Alfrey A.C. (Eds). Aluminium toxicity in infants' health and disease (1997), World Scientific, Singapore 226-237
29. Iqbal K., and Grundke-Iqbal I. Neurofibrillary pathology leads to synaptic loss and not the other way around in Alzheimer disease. J Alzheimer's Dis 4 (2002) 235-238
30. Kawahara M., Muramoto K., Kobayashi K., Mori H., and Kuroda Y. Aluminum promotes the aggregation of Alzheimer's amyloid beta-protein in vitro. Biochem Biophys Res Commun 198 (1994) 531-535
31. Kawahara M., Kato M., and Kuroda Y. Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of beta-amyloid protein. Brain Res Bull 55 (2001) 211-217
32. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S., Cotman C.W., et al. Common structure of soluble amyloid oligomers implies common mechanisms of pathogenesis. Science 300 (2003) 486-489
33. Kellet JM, Taylor A, Oram JJ. Aluminosilicates and Alzheimer's disease. Lancet 1986;i:682.
34. Kerr D.N.S., Ward M.K., Ellis H.A., Simpson W., and Parkinson I.S. Aluminium intoxication in renal disease. Ciba Found Symp 169 (1992) 123-141
35. King G.A., De Boni U., and Crapper D.R. Effect of aluminum upon conditioned avoidance response acquisition in the absence of neurofibrillary degeneration. Pharmacol Biochem Behav 3 (1975) 1003-1009
36. Kong S., Liochev S., and Fridovich I. Aluminum(III) facilitates the oxidation of NADPH by the superoxide anion. Free Radic Biol Med 13 (1992) 79-81
37. Kowall N.W., Pendlebury W.W., Kessler J.B., Perl D.P., and Beal M.F. Aluminum-induced neurofibrillary degeneration affects a subset of neurons in rabbit cerebral cortex, basal forebrain and upper brainstem. Neuroscience 29 (1989) 329-337
38. Levin E.D., Christopher N.C., and Briggs S.J. Chronic nicotinic agonist and antagonist effects on T-maze alternation. Physiol Behav 61 (1997) 863-866
39. Lione A. Aluminum toxicology and the aluminum-containing medications. Pharmacol Ther 29 (1985) 255-285
40. Loeb W.F., and Quimby F.W. The clinical chemistry of laboratory animals. 2nd ed. (1999), CRC Press, Boca Raton p. 651, 678
41. Lukiw W.J., Percy M.E., and Kruck T.P. Nanomolar aluminum induces pro-inflammatory and pro-apoptotic gene expression in human brain cells in primary culture. J Inorg Biochem 99 (2005) 1895-1898
42. Martyn C.N., Barker D.J.P., Osmond C., Harris E.C., Edwardson J.A., and Lacey R.F. Geographical relation between Alzheimer's disease and aluminium in drinking water. Lancet 1 (1989) 59-62
43. Martyn C.N., Coggon D.N., Inskip H., Lacey R.F., and Young W.F. Aluminum concentrations in drinking water and risk of Alzheimer's disease. Epidemiology 8 (1997) 281-286
44. Matsuzaki S., Manabe T., Katayama T., Nishikawa A., Yanagita T., Okuda H., et al. Metals accelerate production of the aberrant splicing isoform of the presenilin-2. J Neurochem 88 (2004) 1345-1351
45. McLachlan D.R.C. Aluminium and the risk for Alzheimer's disease. Environmetrics 6 (1995) 233-275
46. McLachlan D.R.C., Bergeron C., Smith J.E., Roomer D., and Rifat S.L. Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories. Neurology 46 (1996) 401-405
47. Moore P.B., Edwardson J.A., Ferrier I.N., Taylor G.A., Lett D., et al. Gastrointestinal absorption of aluminum is increased in Down's syndrome. Biol Psychiatry 41 (1997) 488-492
48. Moore P.B., Day J.P., Taylor G.A., Ferrier I.N., Fifield L.K., and Edwardson J.A. Absorption of aluminium-26 in Alzheimer's disease, measured using accelerator mass spectrometry. Dement Geriatr Cogn Disord 11 (2000) 66-69
49. Morris C.M., Candy J.M., Oakley A.E., Taylor G.A., Mountfort S., Bishop H., et al. Comparison of the regional distribution of transferrin receptors and aluminium in the forebrain of chronic renal dialysis patients. J Neurol Sci 94 (1989) 295-306
50. Munn N.L. Handbook of psychological research on the rat (1950), Houghton-Mifflin, Boston
51. Naylor G.J., Smith A.H.W., McHarg A., Walker P., Shepherd B., Ward N.I., et al. Raised serum aluminum concentrations in Alzheimer's disease. Trace Elem Psychiatry 6 (1989) 93-95
52. Nunomura A., Perry G., Gjumrakch A., Hirai K., Takeda A., Balraj E.K., et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60 (2001) 759-767
53. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 5th ed. (2005), Elsevier Academic Press, San Diego
54. Pennington J.A.T., and Jones J.W. Dietary intake of aluminium. Aluminum and health: a critical review (1988), Marcel Dekker, New York pp. 67-100
55. Pratico D., Uryu K., Sung S., Tang S., Trojanowski J.W., and Lee V.M.-Y. Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice. FASEB J 16 (2002) 1138-1141
56. Research Animal Resources. Reference values for laboratory animals. University of Minnesota; http://www.ahc.umn.edu/rar/refvalues.html [accessed September 9, 2008].
57. Ricchelli F., Drago D., Filippi B., Tognon G., and Zatta P. Aluminum-triggered structural modifications and aggregation of β-amyloids. Cell Mol Life Sci 62 (2005) 1724-1733
58. Roberts N.B., Clough A., Bellia J.P., and Kim J.Y. Increased absorption of aluminium from a normal dietary intake in dementia. J Inorg Biochem 69 (1998) 171-176
59. Robinson S.R., and Bishop G.M. Aβ as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease. Neurobiol Aging 23 (2002) 1051-1072
60. Rogers M.A., and Simon D.G. A preliminary study of dietary aluminium intake and risk of Alzheimer's disease. Age Ageing 28 (1999) 205-209
61. Rondeau V., Commenges D., Jacqmin-Gadda H., and Dartigues J.F. Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study. Am J Epidemiol 152 (2000) 59-66
62. Saiyed S.M., and Yokel R.A. Aluminium content of some foods and food products in the USA, with aluminium food additives. Food Add Contam 22 (2005) 234-244
63. Shivers B.D., Hilbich C., Multhaup G., Salbaum M., Beyreuther K., and Seeburg P.H. Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. EMBO J 7 (1988) 1365-1370
64. Standards Australia. Determination of aluminium content, graphite furnace atomic absorption spectrometric method. In: Standards Australia AS 4195.1: analysis of serum and plasma for trace elements. Sydney: SAI Global; 1994.
65. Sydney Water Corporation. Warragamba customer supply system [online]; http://www.sydneywater.com.au/WaterQuality/QuarterlyDrinkingWaterQualityReport/ [accessed September 9, 2008].
66. Taylor G.A., Ferrier I.N., McLoughlin I.J., Fairbairn A.F., McKeith I.G., et al. Gastrointestinal absorption of aluminium in Alzheimer's disease: response to aluminium citrate. Age Ageing 21 (1992) 81-90
67. Van Rhijn A., Corrigan F.M., and Ward N.I. Serum aluminum in senile dementia of Alzheimer's type and in multi-infarct dementia. Trace Elem Med 6 (1989) 24-26
68. Walton J. Limited stem cell replication: a clue to the aging process. In: Trump B.F., Jones R.T., and Laufer A. (Eds). Cellular pathobiology of human disease (1983), Fischer Verlag, New York and Stuttgart 369-412
69. Walton J.R. A bright field/fluorescent stain for aluminum: its specificity, validation, and staining characteristics. Biotech Histochem 79 (2004) 169-176
70. Walton J.R. Aluminum in hippocampal neurons from humans with Alzheimer's disease. Neurotoxicology 27 (2006) 385-394
71. Walton J.R. A longitudinal study of rats chronically exposed to aluminum at human dietary levels. Neurosci Lett 412 (2007) 29-33
72. Walton J.R. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration. J Inorg Biochem 101 (2007) 1275-1284
73. WHO. Aluminium. In: 657. Aluminium (WHO food additive series 24); 1989 [online]; http://www.inchem.org/documents/jecfa/jecmono/v024je07.htm [accessed September 9, 2008].
74. Wills M.R., and Savory J. Water content of aluminum, dialysis dementia, and osteomalacia. Environ Health Perspect 63 (1985) 141-147
75. Yamamoto H., Saitoh Y., Yasugawa S., and Miyamoto E. Dephosphorylation of tau factor by protein phosphatase 2A in synaptosomal cytosol fractions, and inhibition by aluminum. J Neurochem 55 (1990) 683-690
76. Yokel R.A., and Florence R.L. Aluminum bioavailability from the approved food additive leavening agent acidic sodium aluminum phosphate, incorporated into a baked good, is lower than from water. Toxicology 227 (2006) 86-93
77. Yokel R.A., Hicks C.L., and Florence R.L. Aluminum bioavailability from basic sodium aluminum phosphate, an approved food additive emulsifying agent, incorporated in cheese. Food Chem Toxicol 46 (2008) 2261-2266
78. Zapatero M.D., Garcia de Jalon A., Pascual F., Calvo M.L., Escanero J., and Marro A. Serum aluminum levels in Alzheimer's disease and other senile dementias. Biol Trace Elem Res 47 (1995) 235-240